Hallucinogen intoxication
Hallucinogen intoxication is a clinically significant transient condition that develops during or shortly after the consumption of hallucinogens that is characterized by disturbances in consciousness, cognition, perception, affect, behavior, or coordination. These disturbances are caused by the known pharmacological effects of hallucinogens and their intensity is closely related to the amount of hallucinogen consumed. They are time-limited and abate as the hallucinogen is cleared from the body. Presenting features may include hallucinations, illusions, perceptual changes such as depersonalisation, derealization, or synesthesias (blending of senses, such as a visual stimulus evoking a smell), anxiety, depressed or dysphoric mood, ideas of reference, paranoid ideation, impaired judgment, palpitations, sweating, blurred vision, tremors and incoordination. Physical signs may include tachycardia, elevated blood pressure, and pupillary dilatation. In rare instances, hallucinogen intoxication may facilitate suicidal ideation and behavior.
How to recognise
In the ICD-11 framework, the core symptoms taken into account when recognising Hallucinogen intoxication are:
- omamy
- iluzje percepcyjne
Differential diagnosis
When diagnosing Hallucinogen intoxication, the following ICD-11 disorders should be considered in the differential diagnosis:
Frequently asked questions
What disorders are in the differential diagnosis of Hallucinogen intoxication?
The differential diagnosis of Hallucinogen intoxication (6C49.3) includes: Zaburzenia transowo-opętaniowe (6B63).
WHO ICD-11 source
View this entry in the official WHO ICD-11 browser: 6C49.3 – WHO ICD-11
Notes
Proszę zakodować również jednostkę chorobową (schorzenie) będące przyczyną
Open in interactive browser →